Last reviewed · How we verify
Single-dose of cannabis oil
Single-dose of cannabis oil is a Small molecule drug developed by Hadassah Medical Organization. It is currently in Phase 3 development for Chronic pain management, Nausea and vomiting associated with chemotherapy.
Cannabis oil modulates the endocannabinoid system to produce therapeutic effects.
Cannabis oil modulates the endocannabinoid system to produce therapeutic effects. Used for Chronic pain management, Nausea and vomiting associated with chemotherapy.
At a glance
| Generic name | Single-dose of cannabis oil |
|---|---|
| Sponsor | Hadassah Medical Organization |
| Target | CB1 and CB2 receptors |
| Modality | Small molecule |
| Therapeutic area | Pain management, Neurology |
| Phase | Phase 3 |
Mechanism of action
The exact mechanisms of cannabis oil are complex and multifaceted, involving the interaction of various cannabinoids with cannabinoid receptors in the brain and body. This interaction can lead to a range of therapeutic effects, including pain relief, reduced inflammation, and improved mood.
Approved indications
- Chronic pain management
- Nausea and vomiting associated with chemotherapy
Common side effects
- Dizziness
- Dry mouth
- Fatigue
- Headache
Key clinical trials
- Cannabis and Polysubstance Use: Response Inhibition and Stress Exposure (PHASE1)
- Effect of Cannabis Extract on Acute Radicular Pain and on Analgesic Requirement (PHASE3)
- Safety and Pharmacokinetics of Extrato de Cannabis Sativa GreenCare (PHASE1)
- Cannabis as a Complementary Treatment in Multiple Sclerosis (PHASE2)
- Investigating a Marijuana-based Compound as a Treatment for Anxiety in Autistic Adults (PHASE2)
- Anesthetic Premedication With a Cannabis Extract (Cannapremed) (PHASE2, PHASE3)
- Cannabinol Use in Patients With Insomnia Disorder (PHASE1, PHASE2)
- A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Single-dose of cannabis oil CI brief — competitive landscape report
- Single-dose of cannabis oil updates RSS · CI watch RSS
- Hadassah Medical Organization portfolio CI
Frequently asked questions about Single-dose of cannabis oil
What is Single-dose of cannabis oil?
How does Single-dose of cannabis oil work?
What is Single-dose of cannabis oil used for?
Who makes Single-dose of cannabis oil?
What development phase is Single-dose of cannabis oil in?
What are the side effects of Single-dose of cannabis oil?
What does Single-dose of cannabis oil target?
Related
- Target: All drugs targeting CB1 and CB2 receptors
- Manufacturer: Hadassah Medical Organization — full pipeline
- Therapeutic area: All drugs in Pain management, Neurology
- Indication: Drugs for Chronic pain management
- Indication: Drugs for Nausea and vomiting associated with chemotherapy
- Compare: Single-dose of cannabis oil vs similar drugs
- Pricing: Single-dose of cannabis oil cost, discount & access